{"id":"W3095177954","doi":"10.1182/blood-2020-134189","title":"Pomalidomide, Dexamethasone, and Daratumumab after Lenalidomide Treatment in Relapsed Refractory Multiple Myeloma: Updated Results from an Open-Label, Multicenter, Phase 2 Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital; McGill University Health Centre","funders":"","keywords":"Pomalidomide; Daratumumab; Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Internal medicine; Oncology; Refractory (planetary science); Phases of clinical research; Thalidomide; Bortezomib; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004825417,0.0008159318,0.002076272,0.0004169603,0.0003810482,0.001997997,0.000730304,0.0009972217,0.00477213],"category_scores_gemma":[0.004979131,0.0003404803,0.002525172,0.0006724352,0.0004908426,0.001384902,0.0005631646,0.003021426,0.0008542837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001132909,"about_ca_system_score_gemma":0.001339562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008581676,"about_ca_topic_score_gemma":0.002702574,"domain_scores_codex":[0.9983193,0.0009111423,0.0001351599,0.0002063893,0.0002672675,0.0001605822],"domain_scores_gemma":[0.9970738,0.0008203229,0.001021365,0.0002355892,0.0003642378,0.000484777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5844304,0.01010188,0.0153912,0.004726664,0.01406133,0.0002457216,0.0003802665,0.001871921,0.006454151,0.0008264956,0.03341038,0.3280996],"study_design_scores_gemma":[0.7732091,0.1052533,0.05690736,0.00167368,0.0136242,0.00101092,0.0002409578,0.001580202,0.002403831,0.001844095,0.04212397,0.000128431],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8499243,0.1065148,0.001430347,0.006854264,0.001421046,0.003236398,0.01497914,0.0002709043,0.015369],"genre_scores_gemma":[0.9403636,0.02604903,0.00308444,0.00778821,0.001068892,0.002633194,0.01574046,0.00008378991,0.003188314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004825417,"threshold_uncertainty_score":0.02551955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0704919808063595,"score_gpt":0.3597267438077629,"score_spread":0.2892347630014034,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}